Reproductive history, as measured by parity, age at first birth and sex of offspring, and cancer-specific survival after a haematological malignancy

References

• Cook MB, McGlynn KA, Devesa SS, et al. Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1629–1637.
   PubMed Web of Science ®Google Scholar
• Micheli A, Ciampichini R, Oberaigner W, et al. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer. 2009;45(6):1017–1027.
   PubMed Web of Science ®Google Scholar
• Radkiewicz C, Johansson ALV, Dickman PW, et al. Sex differences in cancer risk and survival: a Swedish cohort study. Eur J Cancer. 2017;84:130–140.
   PubMed Web of Science ®Google Scholar
• Hedstrom G, Peterson S, Berglund M, et al. Male gender is an adverse risk factor only in young patients with diffuse large B-cell lymphoma – a Swedish population-based study. Acta Oncol. 2015;54(6):924–932.
   PubMed Web of Science ®Google Scholar
• Holmes L Jr., Hossain J, Desvignes-Kendrick M, et al. Sex variability in pediatric leukemia survival: large cohort evidence. ISRN Oncol. 2012;2012:1–9.
   Google Scholar
• Dunford A, Weinstock DM, Savova V, et al. Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat Genet. 2017;49(1):10–16.
   PubMed Web of Science ®Google Scholar
• Li CH, Prokopec SD, Sun RX, et al. Sex differences in oncogenic mutational processes. Nat Commun. 2020;11(1):4330.
   PubMedGoogle Scholar
• Yuan Y, Liu L, Chen H, et al. Comprehensive characterization of molecular differences in cancer between male and female patients. Cancer Cell. 2016;29(5):711–722.
   PubMed Web of Science ®Google Scholar
• Klimm B, Engert A. Differences in hematotoxicity between male and female patients with hodgkin lymphoma and other malignancies. Nat Clin Pract Oncol. 2008;5(6):316–323.
   PubMedGoogle Scholar
• Klimm B, Reineke T, Haverkamp H, et al. Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin study group. J Clin Oncol. 2005;23(31):8003–8011.
   PubMed Web of Science ®Google Scholar
• Kravdal O, Hansen S. The importance of childbearing for Hodgkin's disease: new evidence from incidence and mortality models. Int J Epidemiol. 1996;25(4):737–743.
   PubMedGoogle Scholar
• Møller H, Purushotham A, Linklater KM, et al. Recent childbirth is an adverse prognostic factor in breast cancer and melanoma, but not in Hodgkin lymphoma [research support, Non-U]. Eur J Cancer. 2013;49(17):3686–3693. S
   PubMedGoogle Scholar
• Johansson ALV, Fredriksson I, Mellemkjaer L, et al. Cancer survival in women diagnosed with pregnancy-associated cancer: an overview using nationwide registry data in Sweden 1970–2018. Eur J Cancer. 2021;155:106–115.
   PubMed Web of Science ®Google Scholar
• Weibull CE, Eloranta S, Smedby KE, et al. Pregnancy and the risk of relapse in patients diagnosed with Hodgkin lymphoma. J Clin Oncol. 2016;34(4):337–344.
   PubMedGoogle Scholar
• Derolf AR, Kristinsson SY, Andersson TM, et al. Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood. 2009;113(16):3666–3672.
   PubMed Web of Science ®Google Scholar
• Nabhan C, Zhou X, Day BM, et al. Disease, treatment, and outcome differences between men and women with follicular lymphoma in the United States. Am J Hematol. 2016;91(8):770–775.
   PubMed Web of Science ®Google Scholar
• Jorgensen N, Persson G, Hviid TVF. The tolerogenic function of regulatory T cells in pregnancy and cancer. Front Immunol. 2019;10:911.
   PubMed Web of Science ®Google Scholar
• Nakada D, Oguro H, Levi BP, et al. Oestrogen increases haematopoietic stem-cell self-renewal in females and during pregnancy. Nature. 2014;505(7484):555–558.
   PubMed Web of Science ®Google Scholar
• Sridama V, Pacini F, Yang SL, et al. Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy. N Engl J Med. 1982;307(6):352–356.
   PubMedGoogle Scholar
• Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol. 2010;63(6):425–433.
   PubMed Web of Science ®Google Scholar
• Bryan JN. Fetal microchimerism in cancer protection and promotion: current understanding in dogs and the implications for human health. Aaps J. 2015;17(3):506–512.
   PubMedGoogle Scholar
• Gilmore GL, Haq B, Shadduck RK, et al. Fetal-maternal microchimerism in normal parous females and parous female cancer patients. Exp Hematol. 2008;36(9):1073–1077.
   PubMedGoogle Scholar
• Kamper-Jorgensen M, Hjalgrim H, Andersen AM, et al. Male microchimerism and survival among women. Int J Epidemiol. 2014;43(1):168–173.
   PubMedGoogle Scholar
• Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48(1):27–33.
   PubMed Web of Science ®Google Scholar
• Turesson I, Linet MS, Bjorkholm M, et al. Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964–2003. Int J Cancer. 2007;121(10):2260–2266.
   PubMed Web of Science ®Google Scholar
• Statistics Sweden. Multi-generation register 2016: a description of content and quality. Statistics Sweden; 2017. (Background Facts, Population and Welfare Statistics 2017:2, ISSN 1654-4331)
   Google Scholar
• Lambert PC, Dickman PW, Rutherford MJ. Comparison of different approaches to estimating age standardized net survival. BMC Med Res Methodol. 2015;15:64.
   PubMed Web of Science ®Google Scholar
• Nelson CP, Lambert PC, Squire IB, et al. Flexible parametric models for relative survival, with application in coronary heart disease. Statist Med. 2007;26(30):5486–5498.
   PubMed Web of Science ®Google Scholar
• McKnight B, Cook LS, Weiss NS. Logistic regression analysis for more than one characteristic of exposure. Am J Epidemiol. 1999;149(11):984–992.
   PubMedGoogle Scholar
• Hoekzema E, Barba-Muller E, Pozzobon C, et al. Pregnancy leads to long-lasting changes in human brain structure. Nat Neurosci. 2017;20(2):287–296.
   PubMed Web of Science ®Google Scholar
• Ma H, Bernstein L, Pike MC, et al. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res. 2006;8(4):R43.
   PubMed Web of Science ®Google Scholar
• Ramlakhan KP, Johnson MR, Roos-Hesselink JW. Pregnancy and cardiovascular disease. Nat Rev Cardiol. 2020;17(11):718–731.
   PubMed Web of Science ®Google Scholar
• Ellingjord-Dale M, Vos L, Tretli S, et al. Parity, hormones and breast cancer subtypes – results from a large nested case-control study in a national screening program. Breast Cancer Res. 2017;19(1):10.
   PubMedGoogle Scholar
• Gunderson EP, Chiang V, Lewis CE, et al. Long-term blood pressure changes measured from before to after pregnancy relative to nonparous women. Obstet Gynecol. 2008;112(6):1294–1302.
   PubMedGoogle Scholar
• McCombe PA. The short and long-term effects of pregnancy on multiple sclerosis and experimental autoimmune encephalomyelitis. J Clin Med. 2018;7(12):494.
   PubMedGoogle Scholar
• Roswall N, Olsen A, Christensen J, et al. Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994–2003. Eur J Cancer. 2008;44(14):2058–2073.
   PubMed Web of Science ®Google Scholar
• Biasoli I, Castro N, Delamain M, et al. Lower socioeconomic status is independently associated with shorter survival in Hodgkin lymphoma patients–an analysis from the Brazilian Hodgkin lymphoma registry. Int J Cancer. 2018;142(5):883–890.
   PubMedGoogle Scholar
• Rachet B, Ellis L, Maringe C, et al. Socioeconomic inequalities in cancer survival in England after the NHS cancer plan. Br J Cancer. 2010;103(4):446–453.
   PubMed Web of Science ®Google Scholar
• Ekstrom K, Wuu J, Hsieh CC, et al. Childbearing and the risk of leukemia in Sweden. Cancer Causes Control. 2002;13(1):47–53.
   PubMedGoogle Scholar
• Lambe M, Hsieh CC, Tsaih SW, et al. Childbearing and the risk of Hodgkin's disease. Cancer Epidemiol Biomarkers Prev. 1998;7(9):831–834.
   PubMedGoogle Scholar
• National Care Guidelines for Hodgkin Lymphoma in Sweden, version 2.0, 2019-09-10 [Hodgkins lymfom: Nationellt vårdprogram]. Regional Cancer Centres in Co-operation [cited 2020 Oct 8]. Available from: https://www.cancercentrum.se/samverkan/cancerdiagnoser/blod-lymfom-myelom/lymfom-lymfkortelcancer/vardprogram/
   Google Scholar
• Muller C, Murawski N, Wiesen MH, et al. The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL. Blood. 2012;119(14):3276–3284.
   PubMed Web of Science ®Google Scholar
• Pfreundschuh M, Murawski N, Zeynalova S, et al. Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients. Br J Haematol. 2017;179(3):410–420.
   PubMed Web of Science ®Google Scholar
• Passweg JR, Baldomero H, Bader P, et al. Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually. Bone Marrow Transplant. 2016;51(6):786–792.
   PubMed Web of Science ®Google Scholar